Irving, Texas (RBC Life Sciences: OTCBB: RBCL) — RBC Life Sciences, Inc., a provider of proprietary nutritional supplements and wound care/pain management products, announced today that it has implemented several company-wide initiatives aimed at helping to grow its North American independent sales base.

 

The new initiatives include launching an industry-first compensation plan, giving independent Associates a new back-office platform, streamlining the company’s product offering, changing the name of the company’s network marketing arm and rebranding Websites, product labeling and logos. It also included the August 14 launch of NeuroBright™, a synergistic formulation of antioxidants that improved test subjects’ learning and memory by nearly 50 percent during a recent animal study.

 

“These strategic initiatives and reorganizations better position RBC Life Sciences to capture market share,” said RBC Life Sciences President and CEO, John W. Price. “The compensation plan will reward our independent Associates generously while the new back-office platform will help them monitor, motivate and grow their organizations throughout Canada and the United States.”

 

RBC Life Sciences also changed the name of its network marketing arm to RBC Life™. The new name, along with a streamlined product offering, redesigned labeling and revamped Websites, better reflect the vitality and community aspect of the network marketing company.

 

About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than 30 countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.

 

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

 

SOURCE: RBC Life Sciences

Web site: http://www.rbclifesciences.com/